---
schema_version: "secwatch.filing_event.v1"
accession: "0000926617-26-000042"
form_type: "8-K"
ticker: "AWHL"
cik: "0000926617"
company_name: "Aspira Women's Health Inc."
filed_at: "2026-06-09T11:48:09+00:00"
generated_at: "2026-06-09T11:50:09.111520+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Aspira Women's Health raises ~$1.5M in private placement of common stock and warrants

## Summary
- Issued 3.3M shares and warrants to purchase up to 4.455M shares at $0.45 per unit.
- Gross proceeds of approximately $1.485 million; warrants exercisable at $0.75 for 3 years.
- Net proceeds to be used for working capital and general corporate purposes.
- Closing occurred on June 5, 2026; sold to accredited and institutional investors.

## SEC filing metadata
- accession: 0000926617-26-000042
- form_type: 8-K
- ticker: AWHL
- cik: 0000926617
- company_name: Aspira Women's Health Inc.
- filed_at: 2026-06-09T11:48:09+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/926617/000092661726000042/0000926617-26-000042-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/926617/000092661726000042/awhl-20260529x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000926617-26-000042
- JSON: https://secwatch.observer/filing/0000926617-26-000042.json
- Plain text: https://secwatch.observer/filing/0000926617-26-000042.txt

## Key facts
- Material Agreements
  Aspira Women's Health Inc. entered into Purchase Agreement with accredited and institutional investors valued at approximately $1.485 million (effective 2026-06-05).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: accredited and institutional investors
  - Value: approximately $1.485 million
  - Effective: 2026-06-05
  source text: On June 5, 2026, Aspira Women’s Healthcare Inc. (the “Company”) entered into securities purchase agreements (the “Purchase Agreement”) with accredited and institutional investors (“the “Purchasers”) for the issuance and sale in a private placement (the “Private Placement”) of (i) 3,300,000 shares (the “Shares”) of the Company’s common stock, par value $0.001 (the “Common Stock”) and (ii) warrants (the “Common Warrants”) to purchase up to 4,455,000 shares of the Company’s Common Stock, at a purchase price of $0.45 per share of Common Stock and accompanying warrants.
  evidence_url: https://www.sec.gov/Archives/edgar/data/926617/000092661726000042/0000926617-26-000042-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.